A Case Report of Papillary Thyroid Carcinoma Presenting as Elevated Serum CA 19-9 |
Jang, Eun Kyung
(Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Choi, Yun Mi (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Ho Cheol (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Tae Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Hong, Suck Joon (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Shong, Young Kee (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Won Bae (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Park JK, Yoon YB, Kim YT, et al. Survival and prognostic factors of unresectable pancreatic cancer. Korean J Med 2007;72:151-161. |
2 | Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007;33:266-270. DOI ScienceOn |
3 | Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res 1982;42:4820-4823. |
4 | Matsuura B, Taniguchi Y, Nakanishi K, et al. Serum levels and thyroid tissue expression of CA50 and CA 19-9 in patients with thyroid tumor. Endocrinol Jpn 1991;38:565-571. DOI |
5 | Ogawa M, Hori H, Hirayama M, et al. Anaplastic transformation from papillary thyroid carcinoma with increased serum CA19-9. Pediatr Blood Cancer 2005;45:64-67. DOI ScienceOn |
6 | Vierbuchen M, Schroder S, Uhlenbruck G, Ortmann M, Fischer R. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue. Lab Invest 1989;60:726-732. |
7 | Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004;19:182-186. DOI ScienceOn |
8 | Safi F, Roscher R, Beger HG. Tumor markers in pancreatic cancer: sensitivity and specificity of CA 19-9. Hepatogastroenterology 1989;36:419-423. |
9 | Larena A, Vierbuchen M, Fischer R. Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas. Langenbecks Arch Chir 1995;380:269-272. |